Abstract | OBJECTIVES: High-quality data regarding the efficacy of acid-suppressive treatment for unexplained chest pain are lacking. The aim of this study was to evaluate the efficacy of esomeprazole in primary-care treatment of patients with unexplained chest pain stratified for frequency of reflux/regurgitation symptoms. METHODS: Patients with a ≥ 2-week history of unexplained chest pain (unrelated to gastroesophageal reflux) who had at least moderate pain on ≥ 2 of the last 7 days were stratified by heartburn/regurgitation frequency (≤ 1 day/week (stratum 1) vs. ≥ 2 days/week (stratum 2)) and randomized to 4 weeks of double-blind treatment with twice-daily esomeprazole 40 mg or placebo. Chest pain relief during the last 7 days of treatment (≤ 1 day with minimal symptoms assessed daily using a 7-point scale) was analyzed by stratum in keeping with the predetermined analysis plan. RESULTS: Overall, 599 patients ( esomeprazole: 297, placebo: 302) were randomized. In stratum 1, more esomeprazole than placebo recipients achieved chest pain relief (38.7% vs. 25.5%; P=0.018); no between-treatment difference was observed in stratum 2 (27.2% vs. 24.2%; P=0.54). However, esomeprazole was superior to placebo in a post-hoc analysis of the whole study population (combined strata; 33.1% vs. 24.9%; P=0.035). CONCLUSIONS: A 4-week course of high-dose esomeprazole provided statistically significant relief of unexplained chest pain in primary-care patients who experienced infrequent or no heartburn/regurgitation, but there was no such significant reduction in patients with more frequent reflux symptoms.
|
Authors | Nigel W Flook, Paul Moayyedi, John Dent, Nicholas J Talley, Tore Persson, Björn W Karlson, Magnus Ruth |
Journal | The American journal of gastroenterology
(Am J Gastroenterol)
Vol. 108
Issue 1
Pg. 56-64
(Jan 2013)
ISSN: 1572-0241 [Electronic] United States |
PMID | 23147520
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Administration, Oral
- Adolescent
- Adult
- Aged
- Antacids
(therapeutic use)
- Chest Pain
(drug therapy, etiology)
- Double-Blind Method
- Drug Administration Schedule
- Esomeprazole
(therapeutic use)
- Female
- Gastroesophageal Reflux
(complications)
- Heartburn
(complications)
- Humans
- Intention to Treat Analysis
- Male
- Middle Aged
- Pain Measurement
- Primary Health Care
- Treatment Outcome
- Young Adult
|